Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
The Program for Specialized Treatment Early in Psychosis (STEP) hosted the first U.S. controlled study of early detection (ED) via an NIMH funded study that included a campaign (Mindmap) that ran between 2015-2019 and had two aims. The first was to demonstrate the impact of this ED intervention on community duration of untreated (DUP) psychosis compared to DUP at a control site. The second was to demonstrate that DUP reduction had a positive impact on subsequent patient outcomes in STEP’s first-episode service, or CSC. This presentation will focus on the design and implementation of the campaign, results related to the primary aim of the research project and lessons relevant to real world efforts to improve pathways to care, including reducing DUP. REGISTER HERE
Catherine (Cat) Conroy, M.Ed, Manager of HeadsUp
Neurodevelopment and Psychosis Section, Department of Psychiatry
Perelman School of Medicine, University of Pennsylvania
10th floor, Gates Pavilion, HUP
3400 Spruce Street, Rm. 10054, Philadelphia, PA 19104
headsuppaorg@gmail.com
We are available during standard business hours (Monday-Friday, 9am-5pm) to answer any questions you may have about our organization or to direct you to programs in Pennsylvania that can offer clinical help.
